BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6611459)

  • 1. Characterization of the cells in myeloid leukemia that produce leukemia associated inhibitor (LAI) and demonstration of LAI-producing cells in normal bone marrow.
    Olofsson T; Nilsson E; Olsson I
    Leuk Res; 1984; 8(3):387-96. PubMed ID: 6611459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of leukaemia-associated inhibitor (LAI)-producing cells from normal peripheral blood.
    Olofsson T; Cedergren BM; Persson E
    Scand J Haematol; 1985 Nov; 35(5):511-7. PubMed ID: 3879002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte-macrophage colony-forming cells.
    Olofsson T; Sallerfors B
    Exp Hematol; 1987 Dec; 15(11):1163-7. PubMed ID: 3500070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.
    Olsson I; Olofsson T
    Med Oncol Tumor Pharmacother; 1985; 2(1):1-6. PubMed ID: 3877222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.
    Broxmeyer HE; Bognacki J; Dorner MH; de Sousa M
    J Exp Med; 1981 Jun; 153(6):1426-44. PubMed ID: 6972999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of normal granulopoiesis in vitro by a leukemia associated inhibitor (LAI) derived from a human promyelocytic cell line [HL-60].
    Olofsson T; Olsson I
    Leuk Res; 1980; 4(5):437-47. PubMed ID: 6971969
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor associated myelopoiesis inhibiting factors.
    Olsson I; Olofsson T
    Leuk Res; 1990; 14(8):715-6. PubMed ID: 2201822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia.
    Broxmeyer HE; Grossbard E; Jacobsen N; Moore MA
    N Engl J Med; 1979 Aug; 301(7):346-51. PubMed ID: 313511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2.
    Cukrová V; Hrkal Z; Koprivová H; Neuwirt J
    Blut; 1986 Jan; 52(1):51-8. PubMed ID: 3484646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemopoietic inhibitors in acute leukaemia.
    Vincent PC; Morris TC
    Aust N Z J Med; 1979 Aug; 9(4):455-8. PubMed ID: 389226
    [No Abstract]   [Full Text] [Related]  

  • 11. Acidic isoferritins as feedback regulators in normal and leukemic myelopoiesis.
    Broxmeyer HE; Bognacki J; Dörner MH; deSousa M; Lu L
    Haematol Blood Transfus; 1981; 26():243-5. PubMed ID: 6976289
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of granulopoiesis in patients in the progressive stage of chronic myeloleukemia].
    Nikolov GG; Khoroshko ND
    Gematol Transfuziol; 1984 Nov; 29(11):15-20. PubMed ID: 6597781
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of normal granulopoiesis in vitro by a leukemia-associated inhibitor (LAI) of acute and chronic leukemia.
    Olofsson T; Olsson I
    Blood; 1980 Jun; 55(6):975-82. PubMed ID: 6929716
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus.
    Broxmeyer HE; Ralph P; Gilbertson S; Margolis VB
    Cancer Res; 1980 Nov; 40(11):3928-33. PubMed ID: 6258770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony promoting activity (CPA) produced in long-term culture of murine bone marrow cells.
    Tsurusawa M; Aizawa S; Miyanomae T; Mori KJ
    Leuk Res; 1984; 8(3):377-86. PubMed ID: 6611458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
    Greenberg P; Mara B; Bax I; Brossel R; Schrier S
    Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic cell-associated inhibitory activity against CFU-C of normal bone marrow.
    Itoh K; Fujioka S; Yoshida S
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):47-54. PubMed ID: 3873776
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on hematopoietic stem cells.
    Barton JC
    Ala J Med Sci; 1981 Jul; 18(3):233-5. PubMed ID: 7025679
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical characterization of a leukemia-associated inhibitor (LAI) suppressing normal granulopoiesis in vitro.
    Olofsson T; Olsson I
    Blood; 1980 Jun; 55(6):983-91. PubMed ID: 6246996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of cell-cycle expression of Ia-like antigenic determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins.
    Broxmeyer HE
    J Clin Invest; 1982 Mar; 69(3):632-42. PubMed ID: 6174548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.